These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9188143)

  • 1. Pure silicate fragment in a recurrent stone former of calcium oxalate.
    Ichiyanagi O; Nakada T; Ishigooka M; Hayami S; Sanjo Y; Kubota Y; Nakashima K; Sakai H; Kuwahara M
    Urol Int; 1997; 58(3):192-6. PubMed ID: 9188143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Composition of kidney stone fragments obtained after extracorporeal shock wave lithotripsy.
    Ribeiro da Silva SF; Leite da Silva S; De Francesco Daher E; de Holanda Campos H; Bruno da Silva CA
    Clin Chem Lab Med; 2010 Mar; 48(3):403-4. PubMed ID: 20113249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silica urolithiasis without magnesium trisilicate intake.
    Ichiyanagi O; Sasagawa I; Adachi Y; Suzuki H; Kubota Y; Nakada T
    Urol Int; 1998 Oct; 61(1):39-42. PubMed ID: 9792982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early changes of oxalate and calcium urine excretion in those with calcium oxalate stone formation after extracorporeal shock wave lithotripsy.
    Oehlschläger S; Albrecht S; Hakenberg OW; Schrödter S; Froehner M; Manseck A; Wirth MP
    Urology; 2003 Jul; 62(1):17-21. PubMed ID: 12837412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can a dual-energy computed tomography predict unsuitable stone components for extracorporeal shock wave lithotripsy?
    Ahn SH; Oh TH; Seo IY
    Korean J Urol; 2015 Sep; 56(9):644-9. PubMed ID: 26366277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition by sodium-potassium citrate (CG-120) of calcium oxalate crystal growth on to kidney stone fragments obtained from extracorporeal shock wave lithotripsy.
    Suzuki K; Tsugawa R; Ryall RL
    Br J Urol; 1991 Aug; 68(2):132-7. PubMed ID: 1884137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of mineral water containing calcium and magnesium on calcium oxalate urolithiasis risk factors.
    Rodgers AL
    Urol Int; 1997; 58(2):93-9. PubMed ID: 9096270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experiments with extracorporeal shock wave nephrolithotripsy.
    Li AA; Alekseyeva NI; Andriyanov YuV ; Gerasimov LN
    Int Urol Nephrol; 1989; 21(5):463-7. PubMed ID: 2613476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of chemical and radiographic factors on the treatment of renal lithiasis using extracorporeal external shock-wave lithotripsy].
    Tobelem G; Economou C; Thomas J; Arvis G
    Ann Urol (Paris); 1987; 21(5):362-7. PubMed ID: 3426165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lithotripsy, an individualized design for each stone].
    Burgos Revilla FJ
    Arch Esp Urol; 1993 Oct; 46(8):663-7. PubMed ID: 8311514
    [No Abstract]   [Full Text] [Related]  

  • 11. Stone Composition Among First-Time Symptomatic Kidney Stone Formers in the Community.
    Singh P; Enders FT; Vaughan LE; Bergstralh EJ; Knoedler JJ; Krambeck AE; Lieske JC; Rule AD
    Mayo Clin Proc; 2015 Oct; 90(10):1356-65. PubMed ID: 26349951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Should fragments of stone expelled after extracorporeal lithotripsy always be analyzed?].
    Daudon M; Nguyen HV; Réveillaud RJ; Teillac P; Lombard M; Joerg A; Cortesse A; Le Duc A
    Presse Med; 1990 Feb; 19(6):251-4. PubMed ID: 2138295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of stone composition on operative time during ureteroscopic holmium:yttrium-aluminum-garnet laser lithotripsy with active fragment retrieval.
    Wiener SV; Deters LA; Pais VM
    Urology; 2012 Oct; 80(4):790-4. PubMed ID: 22854140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alkaline citrate in prevention of recurrent calcium oxalate stones.
    Berg C
    Scand J Urol Nephrol Suppl; 1990; 130():1-83. PubMed ID: 2291093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prediction of changes in chemical form of urolithiasis].
    Konstantinova OV; Ianenko ÉK
    Urologiia; 2011; (2):19-23. PubMed ID: 21815453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The composition and quantitative analysis of urinary calculi in patients with renal calculi.
    Jawalekar S; Surve VT; Bhutey AK
    Nepal Med Coll J; 2010 Sep; 12(3):145-8. PubMed ID: 21446361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Etiopathogenesis and clinical aspects of nephrolithiasis--at present].
    Ferrari L; Meschi M; Musini S; Frattini A; Savazzi GM
    Recenti Prog Med; 2003 Mar; 94(3):136-41. PubMed ID: 12677782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosaminoglycan content of Ca-oxalate stone matrix. Effect of this factor on stone fragility.
    Sarica K; Türkölmez K; Küpeli B; Akpoyraz M; Durak I; Küpeli S; Koşar A
    Urol Int; 1997; 58(1):43-6. PubMed ID: 9058520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Two cases of uric acid stones unsuccessfully dissociated by oral chemolysis].
    Funahashi M; Yamada T; Murayama T
    Hinyokika Kiyo; 2006 Jan; 52(1):47-8. PubMed ID: 16479990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of urolithiasis associated with short bowel syndrome].
    Kato Y; Tamaki G; Tokumitsu M; Yamaguchi S; Yachiku S; Okuyama M
    Nihon Hinyokika Gakkai Zasshi; 2003 Jan; 94(1):33-6. PubMed ID: 12638204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.